Zhejiang East Asia Pharmaceutical Co., Ltd. Class ASSE: 605177

"Zhejiang East-Asia Pharmaceutical Co., Ltd."Semi-annual Performance Forecast for 2026

Jul 15, 2026 · Issued by Zhejiang East Asia Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange

Semi-annual Performance Forecast for 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Zhejiang East Asia Pharmaceutical Co., Ltd. Class A

"Zhejiang East-Asia Pharmaceutical Co., Ltd."Announcement on Not Revising Downward the Conversion Price of "East-Asia Convertible Bonds"Jul 9
"Zhejiang East-Asia Pharmaceutical Co., Ltd."Indicative Announcement on "East-Asia Convertible Bonds" Expected to Meet Conditions for Revising Conversion PriceJul 2
"Zhejiang East-Asia Pharmaceutical Co., Ltd."Announcement on Repurchasing and Canceling Restricted Stocks Granted to Some Incentive Objects But Not Yet Lifted from Sales RestrictionsJul 1
Announcement on 2026 Interest Payment of "East-Asia Convertible Bonds"Jun 30

All Zhejiang East Asia Pharmaceutical Co., Ltd. Class A news releases